Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin)

NCT00955110 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Oxymorphone ER
DRUG: Oxycodone CR
DRUG: Placebo
DRUG: Hydromorphone

Sponsor

Endo Pharmaceuticals

Collaborators

[object Object]